Tumor Board: How new data in cervical cancer effects second-line treatment options

Description

Recorded Live: August 31, 2022

Speaker & Presentation Information

Moderator:

Ritu Salani, MD
University of California, Los Angeles
USA

Panelists:

Nicoletta Colombo, MD
European Institute of Oncology and University of Milan-Bicocca
Italy

Leslie Randall, MD
Virginia Commonwealth University
USA

Supported in part by

Summary


Availability:	On-Demand


Cost:	FREE

Create Account

Recommended

Novel combinations for treatment of recurrent cervical cancer

FREE

Second-Line Treatment Options for Patients with Recurrent Cervical Cancer. Review of Current Treatment and Future Directions

FREE

Radical Hysterectomy - Surgical Film Festival

$0.00 - $50.00

An Evolving Frontier: Endometrial Cancer Treatment

FREE

Immunotherapy and its impact on overall survival in patients with recurrent endometrial cancer

FREE

International Gynecologic Cancer Society and International Journal of Gynecological Cancer Evidence-Based Medicine for Gynecological Oncology Curriculum (EBM on the GO)

FREE

Emerging data in platinum resistance advanced ovarian cancer - Webinar

FREE

Newly Opened Phase 3 Study for Low Grade Serous Ovarian Cancer - Webinar

FREE

Uterine mesenchymal neoplasms: new and evolving entities - Webinar

FREE

Newly Opened Phase 3 Study for Low Grade Serous Ovarian Cancer

FREE